Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-8722

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy ; volume:9 ; number:1 ; day:27 ; month:5 ; year:2016 ; pages:1-21 ; date:12.2016
Journal of hematology & oncology ; 9, Heft 1 (27.5.2016), 1-21, 12.2016

Creator: Ma, Weijie

Contributor: Gilligan, Barbara M.
Yuan, Jianda
Li, Tianhong
SpringerLink (Online service)

DOI: 10.1186/s13045-016-0277-y

URN: urn:nbn:de:101:1-2018091116150239266549

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ma, Weijie
Gilligan, Barbara M.
Yuan, Jianda
Li, Tianhong
SpringerLink (Online service)

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers

Enhancing cancer care with improved checkpoint inhibitors : a focus on PD-1/PD-L1

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers

Enhancing cancer care with improved checkpoint inhibitors : a focus on PD-1/PD-L1

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers

Enhancing cancer care with improved checkpoint inhibitors : a focus on PD-1/PD-L1

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers

Enhancing cancer care with improved checkpoint inhibitors : a focus on PD-1/PD-L1

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers

Enhancing cancer care with improved checkpoint inhibitors : a focus on PD-1/PD-L1

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies

High-resolution PET imaging with therapeutic antibody-based PD-1/PD-L1 checkpoint tracers

Enhancing cancer care with improved checkpoint inhibitors : a focus on PD-1/PD-L1

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Related objects

Reset password